Severity and mortality of acute respiratory failure in pediatrics: A prospective multicenter cohort in Bogotá, Colombia.

Background and Aims: Acute respiratory failure (ARF) is the most frequent cause of cardiorespiratory arrest and subsequent death in children worldwide. There have been limited studies regarding ARF in high altitude settings. The aim of this study was to calculate mortality and describe associated factors for severity and mortality in children with ARF. Methods: The study was conducted within a prospective multicentric cohort that evaluated the natural history of pediatric ARF. For this analysis three primary outcomes were studied: mortality, invasive mechanical ventilation, and pediatric intensive care unit (PICU) length of stay. Eligible patients were children older than 1 month and younger than 18 years of age with respiratory difficulty at the time of admission. Patients who developed ARF were followed at the time of ARF, 48 h later, at the time of discharge, and at 30 and 60 days after discharge. It was conducted in the pediatric emergency, in-hospital, and critical-care services in three hospitals in Bogotá, Colombia, from April 2020 to June 2021. Results: Out of a total of 685 eligible patients, 296 developed ARF for a calculated incidence of ARF of 43.2%. Of the ARF group, 90 patients (30.4%) needed orotracheal intubation, for a mean of 9.57 days of ventilation (interquartile range = 3.00-11.5). Incidence of mortality was 6.1% (n = 18). The associated factors for mortality in ARF were a history of a neurologic comorbidity and a higher fraction of inspired oxygen at ARF diagnosis. For PICU length of stay, the associated factors were age between 2 and 5 years of age, exposure to smokers, and respiratory comorbidity. Finally, for mechanical ventilation, the risk factors were obesity and being unstable at admission. Conclusions: ARF is a common cause of morbidity and mortality in children. Understanding the factors associated with greater mortality and severity of ARF might allow earlier recognition and initiation of prompt treatment strategies.

Burden of respiratory failure in pediatric patients: Analysis of a prospective multicenter cohort in Bogotá, Colombia.

Background and Aims: The approach to the burden of disease is a demographic, economic, and a health problem, which requires the design and application of specific measures of cost of the disease, such as disability-adjusted life years (DALYs), to establish better public health policies in the pediatric population. The aim of this study is to approach the burden of disease in children with acute respiratory failure (ARF) through the calculation of DALYs. Methods: This study was conducted in the framework of a prospective, multicenter cohort in Bogotá, Colombia. Inclusion criteria were all pediatric patients admitted to the emergency department, hospitalization, and intensive care unit with respiratory distress; eligible patients were all those who developed ARF between April 2020 and December 2021. They were followed-up during hospitalization, at 30 and 60 days after admission. The Infant/Toddler Quality of Life Questionnaire and KIDSCREEN quality of life scales were applied for follow-up according to the age group. The results were used to calculate DALYs. Results: Six hundred and eighty-five eligible patients, 296 (43.08%) developed ARF, of these 22 (6.08%) patients died (mortality rate = 7.43%). The total DALYs was 277.164 years. For younger than 9 years, the DALYs were 302.64 years, while for older than 10 years were 40.49 years. Conclusion: ARF is one of the main causes of preventable mortality in pediatrics, its progression to respiratory failure is a highly prevalent condition in pediatric age, a condition that has a great impact on mortality, morbidity, and disability in our patients.

Therapeutic efficacy test in malaria falciparum in Antioquia, Colombia.

OBJECTIVE: Evaluate the frequency of failure of eight treatments for non-complicated malaria caused by Plasmodium falciparum in patients from Turbo (Urabá region), El Bagre and Zaragoza (Bajo Cauca region), applying the 1998 protocol of the World Health Organization (WHO). Monotherapies using chloroquine (CQ), amodiaquine (AQ), mefloquine (MQ) and sulphadoxine-pyrimethamine (SP), and combinations using chloroquine-sulphadoxine-pyrimethamine (CQ-SP), amodiaquine-sulphadoxine-pyrimethamine (AQ-SP), mefloquine-sulphadoxine-pyrimethamine (MQ-SP) and artesunate-sulphadoxine-pyrimethamine (AS-SP), were examined. METHODOLOGY: A balanced experimental design with eight groups. Samples were selected based on statistical and epidemiological criteria. Patients were followed for 21 to 28 days, including seven or eight parasitological and clinical evaluations, with an active search for defaulting patients. A non-blinded evaluation of the antimalarial treatment response (early failure, late failure, adequate response) was performed. RESULTS: Initially, the loss of patients to follow-up was higher than 40%, but the immediate active search for the cases and the monetary help for transportation expenses of patients, reduced the loss to 6%. The treatment failure was: CQ 82%, AQ 30%, MQ 4%, SP 24%, CQ-SP 17%, AQ-SP 2%, MQ-S-P 0%, AS-SP 3%. CONCLUSION: The characteristics of an optimal epidemiological monitoring system of antimalarial treatment response in Colombia are discussed. It is proposed to focus this on early failure detection, by applying a screening test every two to three years, based on a seven to 14-day follow-up. Clinical and parasitological assessment would be carried out by a general physician and a field microscopist from the local hospital, with active measures to search for defaulter patients at follow-up.

Randomized, multicenter trial of conventional ventilation versus high-frequency oscillatory ventilation for the early management of respiratory failure in term or near-term infants in Colombia.

OBJECTIVE: To determine the efficacy and safety of high-frequency oscillatory ventilation (HFOV) compared to conventional ventilation (CV) for the treatment of respiratory failure in term and near-term infants in Colombia. STUDY DESIGN: Eligible infants with moderate to severe respiratory failure were randomized to early treatment with CV or HFOV. Ventilator management and general patient care were standardized. The main outcome was neonatal death or pulmonary air leak. RESULTS: A total of 119 infants were enrolled (55 in the HFOV group; 64 in the CV group) during the study period. Six infants in the HFOV group (11%) and two infants in the CV group (3%) developed the primary outcome (RR: 3.6, 95% CI: 0.8-16.9). Five infants in the HFOV group (9%) and one infant in the CV (2%) died before 28 days of life (RR: 5.9 CI: 0.7-48.2). Secondary outcomes were similar between groups. CONCLUSION: HFOV may not be superior to CV as an early treatment for respiratory failure in this age group. Standardization of ventilator management and general patient care may have a greater impact on the outcome in Colombia than mode of ventilation.

Risk factors for nosocomial infections in selected neonatal intensive care units in Colombia, South America.

OBJECTIVE: This study was designed to identify risk factors for nosocomial infections among infants admitted into eight neonatal intensive care units in Colombia. Knowledge of modifiable risk factors could be used to guide the design of interventions to prevent the problem. STUDY DESIGN: Data were collected prospectively from eight neonatal units. Nosocomial infection was defined as culture-proven infection diagnosed after 72 hours of hospitalization, resulting in treatment with antibiotics for >3 days. Associations were expressed as odds ratios. Logistic regression was used to adjust for potential confounders. RESULTS: From a total of 1504 eligible infants, 80 were treated for 127 episodes of nosocomial infection. Logistic regression analysis identified the combined exposure to postnatal steroids and H2-blockers, and use of oral gastric tubes for enteral nutrition as risk factors significantly associated with nosocomial infection. CONCLUSION: Nosocomial infections in Colombian neonatal intensive care units were associated with modifiable risk factors including use of postnatal steroids and H2-blockers.

Epidemiology of nosocomial infections in selected neonatal intensive care units in Colombia, South America.

OBJECTIVE: The epidemiology of nosocomial infections (NI) in neonatal intensive care units in developing countries has been poorly studied. We conducted a prospective study in selected neonatal units in Colombia, SA, to describe the incidence rate, causative organisms, and interinstitutional differences. STUDY DESIGN: Data were collected prospectively from February 20 to August 30, 2001 from eight neonatal units. NI was defined as culture-proven infection diagnosed after 72 h of hospitalization, resulting in treatment with antibiotics for >3 days. Linear regression models were used to describe associations between institutional variables and NI rates. RESULTS: A total of 1504 infants were hospitalized for more than 72 h, and therefore, at risk for NI. Of all, 127 infections were reported among 80 patients (5.3%). The incidence density rate was 6.2 per 1000 patient-days. Bloodstream infections accounted for 78% of NIs. Gram-negative organisms predominated over gram-positive organisms (55 vs 38%) and were prevalent in infants < or =2000 g (54%). The most common pathogens were Staphylococcus epidermidis (26%) and Klebsiella pneumonia (12%). CONCLUSION: Gram-negative organisms predominate in Colombia among infants <2000 g. The emergence of gram-negative organisms and their associated risk factors requires further study.

Complicaciones de la caterización venosa central según la vía de inserción en pacientes pediátricos / Complications of central venous catherization according to site of insertion in pediatric patients

Objetivos: comparar el riesgo de presentar complicaciones mecánicas e infecciosas entre las vías superiores (subclavias y yugulares internas) y las vías inferiores (femoral). Materiales y métodos: estudio analítico de cohortes. En forma prospectiva se recolectó la información correspondiente. Población de estudio: pacientes menores de 16 años hospitalizados en la Fundación Santa Fe de Bogotá (FSFB) entre 01/01/91 y 31/12/02 con catéter venoso central (CVC) por vías yugular, subclavia y femoral. Resultados: se estudiaron en total 1475 CVC, 535 a través de las venas superiores, 134 (25 por ciento) insertados por vena subclavia (VS) y 401 (75 por ciento) por vena yugular interna (VYI). El riesgo de desarrollar Bacteriemia relacionada con el CVC (BRC) fue 1,8 por ciento (18/996) para los insertados por vía superior y 3,13 por ciento (15/479) para los insertados por vía inferior, (p=0,10). La incidencia de trombosis fue 0 por ciento en los catéteres superiores (0/996) en contraste con 1,2 por ciento (6/479) de los catéteres inferiores (P=0,00 04). Conclusiones: el riesgo de presentar complicaciones mecánicas fue similar en nuestro estudio entre las vías yugular y subclavia, el riesgo de presentar BRC no difirió entre los abordajes superior e inferior, el riesgo de trombosis venosa fu e estadísticamente más alto con los catéteres femorales aun que la relevancia clínica de esta diferencia es discreta

Dieta con o sin lactosa en niños con enfermedad diarreica aguda: un meta-análisis de la literatura

La eficacia de las dietas libres de lactosa en forma rutinaria en niños menores de tres años con enfermedad diarreica aguda, en comparación con dietas con lactosa, no ha sido demostrada en forma consistente y significativa a pesar de múltiples estudios realizados. Para determinar si esta diferencia existe, se diseñó un meta-análisis que nos permitió reunir cuantitativamente los resultados de 15 experimentos clínicos controlados, con un total de 1.364 pacientes, seleccionados por su adecuada calidad metodológica, que intentaban responder la hipótesis planteada. Los parámetros evaluados fueron: 1. Duración de la diarrea en días o enhoras medida como la diferencia (tiempo con lactosa-tiempo sin lactosa). 2. Falla terapéutica medida por el RRI (Odds radio: Con lactosa/Sin lactosa). y 3. La ganancia ponderal teniendo en cuenta variación en el peso post-tratamiento respecto al ingreso. El análisis indicó que no hay diferencias estadísticamente significativas en cuanto a la duración de la diarrea en días (0,03 días con IC 95 por ciento -0.4 a +0,3). Sin embargo, al anlizar los estudios que informaron la duración de la diarrea en horas, sugieren que la dieta con lactosa puede incrementar en algunas horas su duración (+12,8 horas con IC 95 por ciento +4,1 a +21,5). En cuanto al análisis por falla terapéutica, sugiere que en conjunto los niños que reciben lactosa tienen un riesgo aproximadamente 2 veces mayor que los que no la reciben (RRI 1,91 con IC 95 por ciento 1,28 a 2,86). Los resultados sugieren que el empleo rutinario de dietas sin lactosa en niños con enfermedad diarreica aguda (EDA) puede producir resultados diferentes según la variable empleada para medir la efectividad. La diferencia obtenida en duración por horas no tiene importancia clínica. La diferencia obtenida en cuanto a falla terapéutica está a favor de la utilización de fórmulas libres de lactosa.